Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant

NCT01593215 is registered in ClinicalTrials.gov with Anders Rosengren, MD PhD as lead sponsor.

NCT NCT01593215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01593215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant
Lead sponsor
Anders Rosengren, MD PhD
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
October 31, 2014
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes